Healthcare provider profile · identity verified

James Luecke, MD

Family Practice · FORT DAVIS, TX · NPI 1184692881

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	464	131
Lisinopril	Lisinopril	256	76
Atorvastatin Calcium	Atorvastatin Calcium	235	63
Alprazolam	Alprazolam	213	30
Pantoprazole Sodium	Pantoprazole Sodium	197	67
Amlodipine Besylate	Amlodipine Besylate	188	50
Gabapentin	Gabapentin	182	52
Tamsulosin Hcl	Tamsulosin Hcl	167	51
Rosuvastatin Calcium	Rosuvastatin Calcium	164	48
Losartan Potassium	Losartan Potassium	157	42
Methylprednisolone	Methylprednisolone	152	112
Tramadol Hcl	Tramadol Hcl	148	40
Metoprolol Succinate	Metoprolol Succinate	144	32
Metformin Hcl	Metformin Hcl	143	40
Escitalopram Oxalate	Escitalopram Oxalate	135	24
Potassium Chloride	Potassium Chloride	113	39
Furosemide	Furosemide	94	31
Azithromycin	Azithromycin	89	72
Zolpidem Tartrate	Zolpidem Tartrate	82	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	79	13
Clonazepam	Clonazepam	76	15
Allopurinol	Allopurinol	71	18
Trazodone Hcl	Trazodone Hcl	69	23
Carvedilol	Carvedilol	64	19
Montelukast Sodium	Montelukast Sodium	64	28
Synthroid	Levothyroxine Sodium	62	26
Citalopram Hbr	Citalopram Hydrobromide	58	13
Albuterol Sulfate Hfa	Albuterol Sulfate	57	25
Ciprofloxacin Hcl	Ciprofloxacin Hcl	57	48
Eliquis	Apixaban	57	11
Hydrochlorothiazide	Hydrochlorothiazide	57	19
Bupropion Xl	Bupropion Hcl	53	11
Jardiance	Empagliflozin	52	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	49	15
Pregabalin	Pregabalin	49	suppressed
Duloxetine Hcl	Duloxetine Hcl	48	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	17
Fluticasone Propionate	Fluticasone Propionate	43	19
Januvia	Sitagliptin Phosphate	43	suppressed
Omeprazole	Omeprazole	43	15
Triamcinolone Acetonide	Triamcinolone Acetonide	42	17
Diclofenac Sodium	Diclofenac Sodium	41	18
Tradjenta	Linagliptin	41	suppressed
Clopidogrel	Clopidogrel Bisulfate	40	12
Lorazepam	Lorazepam	40	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	40	14
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	38	22
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	37	25
Fluoxetine Hcl	Fluoxetine Hcl	37	suppressed
Sucralfate	Sucralfate	36	17
Xarelto	Rivaroxaban	36	suppressed
Linzess	Linaclotide	35	14
Prednisone	Prednisone	33	suppressed
Cephalexin	Cephalexin	32	26
Pravastatin Sodium	Pravastatin Sodium	32	suppressed
Simvastatin	Simvastatin	32	suppressed
Celecoxib	Celecoxib	30	12
Farxiga	Dapagliflozin Propanediol	30	suppressed
Ezetimibe	Ezetimibe	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Valacyclovir	Valacyclovir Hcl	29	16
Armour Thyroid	Thyroid,pork	27	suppressed
Glipizide Er	Glipizide	27	suppressed
Ozempic	Semaglutide	27	suppressed
Alendronate Sodium	Alendronate Sodium	26	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	26	suppressed
Fluconazole	Fluconazole	26	12
Metformin Hcl Er	Metformin Hcl	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	18
Sertraline Hcl	Sertraline Hcl	25	suppressed
Symbicort	Budesonide/Formoterol Fumarate	25	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Acyclovir	Acyclovir	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Finasteride	Finasteride	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	19
Spironolactone	Spironolactone	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Atenolol	Atenolol	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Nebivolol Hcl	Nebivolol Hcl	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Tobramycin-Dexamethasone	Tobramycin/Dexamethasone	19	13
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	18	suppressed
Famotidine	Famotidine	18	suppressed
Ibuprofen	Ibuprofen	18	12
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	18	suppressed
Cefdinir	Cefdinir	17	14
Fludrocortisone Acetate	Fludrocortisone Acetate	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Ondansetron Odt	Ondansetron	17	13
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	16	suppressed
Mounjaro	Tirzepatide	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Levofloxacin	Levofloxacin	15	12
Novolog Flexpen	Insulin Aspart	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	13
Telmisartan	Telmisartan	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Progesterone	Progesterone, Micronized	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Estradiol	Estradiol	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Metronidazole	Metronidazole	12	11
Nitroglycerin	Nitroglycerin	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Budesonide Dr	Budesonide	11	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	11	suppressed
Ibu	Ibuprofen	11	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Nurtec Odt	Rimegepant Sulfate	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error